Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 23:33:02 - browse：33988

The building exterior of AstraZeneca, a pharmaceutical and biopharmaceutical company, under cloudless blue sky — coverage from STAT — Adobe

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them.

AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process. But Colm Connolly, chief judge of the U.S. District Court of Delaware, said he doesn’t understand how the law deprives AstraZeneca of its property. He asked Catherine Stetson, who represents AstraZeneca, multiple times to explain what property the company would lose due to Medicare price negotiation. Stetson said it’s both the patent and the drug that’s subject to the patent.

“You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. “You may not make as much money.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Thermo Fisher plant for manufacturing gene therapies to expand

entertainment

WSS

AstraZeneca bets AAV gene therapy will still deliver the goods

Senate HELP committee spars over health care workforce policies

Apellis safety probe of eye disease drug centers on injection needle

Winners, losers from Medicare’s list of drugs subject to price talks

Study finds new variant for Parkinson’s in African populations

Lasker Awards 2023: Winners in biomedical research

hotspot

Wikipedia

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Senate HELP committee spars over health care workforce policies

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ukraine and a new approach to mental health in war

At least 13 dead in Texas as scorching temps continue

Feds fine Medicare Advantage plans for overcharging members

Apple is now the first public company to be valued at $3 trillion

Lasker Awards 2023: Winners in biomedical research

Hepatitis C has a cure — but many Americans still lack access to it

Intarcia’s device

focus

Winners, losers from Medicare’s list of drugs subject to price talks

In science, is the line between industry and academia shifting?

How a symptom of dementia informs our understanding of creativity

AstraZeneca challenges Medicare drug negotiation program

How Vertex's cystic fibrosis drug is changing patients' lives

Psilocybin's anti

entertainment

knowledge

entertainment

knowledge